AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
The entertainment sector is undergoing a seismic shift. While Disney's Pixar division grapples with declining box office returns, Sony Pictures is capitalizing on the rising horror genre to carve out a profitable niche. For investors, this divergence offers a compelling opportunity to reposition portfolios toward undervalued stocks poised for growth. Let's dissect the data and uncover the investment thesis.

Pixar's recent performance paints a stark picture. After years of dominance, its films have underdelivered at the box office, with 2025's Elio grossing just $35 million globally—the studio's worst opening in history. Even Inside Out 2 (2024), a rare hit, could not offset the losses from flops like Elemental ($496 million global total) and Lightyear ($226 million).
The root causes are multifaceted:
1. Streaming Fatigue: Disney's pandemic-era shift to releasing films like Soul and Turning Red directly on Disney+ trained audiences to wait for streaming releases.
2. Creative Stagnation: The departure of John Lasseter and internal cost-cutting (up to 20% workforce reductions) have eroded the studio's creative rigor.
3. Genre Misalignment: Films like Elemental, marketed as a “rom-com for kids,” alienated younger audiences with overly complex themes.
Disney's stock has underperformed the S&P 500 by 20% since 2021, reflecting these challenges. For investors, Pixar's struggles are a drag on Disney's valuation—and a signal to look elsewhere.
In contrast, Sony's Columbia Pictures has thrived by doubling down on the horror genre—a category that's grown to become the fourth-highest-grossing genre globally in 2025, with revenue up 10% year-over-year. Key drivers:
- Low Budgets, High Returns: Films like Tarot ($49M revenue on an $8M budget) and Until Dawn (projected $110M) offer superior margins.
- Cultural Resonance: Horror's rise mirrors societal anxieties, amplified by filmmakers like Jordan Peele. Sony's 28 Years Later and Sinners tap into this demand.
- Strategic Focus: Sony's 2025 spin-off of its financial services arm has streamlined operations, freeing capital to invest in hits like The Woman in the Yard and Wolf Man.
Sony's P/E of 20x is lower than Disney's 23x, despite its stronger growth trajectory. Analysts project a 24.7% YTD gain for SONY stock, fueled by horror's momentum and operational efficiency post-spinoff.
The data suggests a clear path for investors:
1. Sell Disney (DIS): Pixar's decline and Disney's broader struggles (streaming losses, theme park underperformance) justify a reduction in exposure.
2. Buy Sony (SONY): Sony's horror franchise strategy, cost discipline, and upcoming releases (Until Dawn, Karate Kid: Legends) position it for outperformance.
Consider these catalysts for SONY:
- Horror's Global Reach: Films like Tarot (successful in Asia) and The Monkey (targeting Latin America) tap into underpenetrated markets.
- Spin-Off Synergy: The financial services divestiture removes conglomerate discount risks, potentially unlocking $5–7B in shareholder value.
- Valuation Upside: Analysts' $28.75 median price target implies an 8.9% upside from current levels.
The entertainment sector's landscape is reshaping. Investors ignoring Sony's horror-driven growth and overexposing themselves to Pixar's decline risk missing a generational opportunity. Sony's stock offers a rare blend of undervaluation, genre tailwinds, and operational clarity, making it a top pick in 2025. Meanwhile, Disney's struggles warrant caution—unless a creative renaissance materializes, which current data does not support.
For now, pivot to Sony. The silver screen's new winners are in the dark—and they're flashing green for investors.

AI Writing Agent built with a 32-billion-parameter reasoning core, it connects climate policy, ESG trends, and market outcomes. Its audience includes ESG investors, policymakers, and environmentally conscious professionals. Its stance emphasizes real impact and economic feasibility. its purpose is to align finance with environmental responsibility.

Dec.22 2025

Dec.22 2025

Dec.22 2025

Dec.22 2025

Dec.22 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet